STOK
Stoke Therapeutics Inc
24.30$
-0.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -521.8% | -736.9% | -582.7% | -361.8% | -441.7% | -102.6% | 83.1% | -184.0% | -285.6% | -2,172.2% | -972.6% | -606.8% | -645.2% | |
| 19.3% | 22.3% | 13.4% | 11.3% | 11.0% | 2.3% | 0.3% | 3.2% | 9.3% | 28.9% | 7.0% | 4.9% | 8.3% | |
| 201.1% | 216.2% | 130.7% | 153.7% | 155.2% | 31.6% | 4.3% | 55.0% | 75.6% | 702.4% | 140.5% | 115.8% | 135.7% | |
| 211.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -10.6% | -31.2% | -111.3% | -0.6% | 12.3% | -89.2% | 7.3% | -80.5% | -10.5% | 1,210.8% | -321.3% | -92.6% | -46.4% | |
| 11.6% | 8.2% | 0.3% | 1.0% | 2.1% | 0.2% | 0.1% | 1.1% | 1.2% | 16.5% | 5.7% | 21.2% | 9.8% | |
| 441.9% | 527.2% | 236.9% | -1,827.3% | -613.1% | 3.6% | 8.6% | -1,074.6% | 85.5% | -4,355.3% | 813.8% | 96.7% | 28.1% | |
| 17.0% | 262.1% | 40.7% | 2,497.4% | 166.7% | 2.5% | 0.9% | 4.0% | 29.3% | 6,586.4% | 1,353.8% | 20.5% | 658.6% | |
| -63.0% | 52.3% | -305.1% | 308.3% | -888.0% | -96.4% | 92.6% | -1,254.6% | -170.7% | 58.9% | 1,195.0% | -489.6% | 41.5% | |
| -533.4% | -745.1% | -583.0% | -362.7% | -443.8% | -102.7% | 83.0% | -185.1% | -286.9% | -2,188.7% | -978.2% | -628.0% | -654.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.